NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Certara Inc (NASDAQ: CERT)

 
CERT Technical Analysis
4
As on 9th Jun 2023 CERT STOCK Price closed @ 17.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 19.90 & Strong Sell for SHORT-TERM with Stoploss of 25.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CERTSTOCK Price

Open 17.29 Change Price %
High 17.80 1 Day -0.25 -1.45
Low 16.95 1 Week -4.22 -19.89
Close 17.00 1 Month -6.99 -29.14
Volume 1969524 1 Year -10.48 -38.14
52 Week High 29.70 | 52 Week Low 10.65
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
CERT
Daily Charts
CERT
Intraday Charts
Whats New @
Bazaartrend
CERT
Free Analysis
 
CERT Important Levels Intraday
RESISTANCE18.64
RESISTANCE18.11
RESISTANCE17.79
RESISTANCE17.46
SUPPORT16.54
SUPPORT16.21
SUPPORT15.89
SUPPORT15.36
 
CERT Forecast May 2024
4th UP Forecast26.89
3rd UP Forecast23.72
2nd UP Forecast21.76
1st UP Forecast19.8
1st DOWN Forecast14.2
2nd DOWN Forecast12.24
3rd DOWN Forecast10.28
4th DOWN Forecast7.11
 
CERT Weekly Forecast
4th UP Forecast20.89
3rd UP Forecast19.64
2nd UP Forecast18.87
1st UP Forecast18.10
1st DOWN Forecast15.90
2nd DOWN Forecast15.13
3rd DOWN Forecast14.36
4th DOWN Forecast13.11
 
CERT Forecast2024
4th UP Forecast54.36
3rd UP Forecast42.38
2nd UP Forecast34.97
1st UP Forecast27.57
1st DOWN Forecast6.43
2nd DOWN Forecast-0.97
3rd DOWN Forecast-8.38
4th DOWN Forecast-20.36
 
 
CERT Other Details
Segment EQ
Market Capital 6584151040.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CERT Address
CERT
 
CERT Latest News
 
Your Comments and Response on Certara Inc
 
CERT Business Profile
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. Address: 100 Overlook Center, Princeton, NJ, United States, 08540
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service